Boston Scientific Corporation (BSX)
NYSE: BSX · Real-Time Price · USD
87.59
-1.18 (-1.33%)
At close: Nov 14, 2024, 4:00 PM
87.48
-0.11 (-0.13%)
Pre-market: Nov 15, 2024, 7:00 AM EST
Boston Scientific Employees
Boston Scientific had 48,000 employees as of December 31, 2023. The number of employees increased by 3,000 or 6.67% compared to the previous year.
Employees
48,000
Change (1Y)
3,000
Growth (1Y)
6.67%
Revenue / Employee
$331,479
Profits / Employee
$37,354
Market Cap
129.09B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 48,000 | 3,000 | 6.67% |
Dec 31, 2022 | 45,000 | 4,000 | 9.76% |
Dec 31, 2021 | 41,000 | 3,000 | 7.89% |
Dec 31, 2020 | 38,000 | 2,000 | 5.56% |
Dec 31, 2019 | 36,000 | 4,000 | 12.50% |
Dec 31, 2018 | 32,000 | 3,000 | 10.34% |
Dec 31, 2017 | 29,000 | 2,000 | 7.41% |
Dec 31, 2016 | 27,000 | 2,000 | 8.00% |
Dec 31, 2015 | 25,000 | 1,000 | 4.17% |
Dec 31, 2014 | 24,000 | 1,000 | 4.35% |
Dec 31, 2013 | 23,000 | -1,000 | -4.17% |
Dec 31, 2012 | 24,000 | 0 | - |
Dec 31, 2011 | 24,000 | -1,000 | -4.00% |
Dec 31, 2010 | 25,000 | -1,000 | -3.85% |
Dec 31, 2009 | 26,000 | 1,200 | 4.84% |
Dec 31, 2008 | 24,800 | -2,700 | -9.82% |
Dec 31, 2007 | 27,500 | -1,100 | -3.85% |
Dec 31, 2006 | 28,600 | 8,800 | 44.44% |
Dec 31, 2005 | 19,800 | 2,300 | 13.14% |
Dec 31, 2004 | 17,500 | 2,500 | 16.67% |
Dec 31, 2003 | 15,000 | 1,100 | 7.91% |
Dec 31, 2002 | 13,900 | -500 | -3.47% |
Dec 31, 2001 | 14,400 | 680 | 4.96% |
Dec 31, 2000 | 13,720 | 1,105 | 8.76% |
Dec 31, 1999 | 12,615 | -1,385 | -9.89% |
Dec 31, 1998 | 14,000 | 3,000 | 27.27% |
Dec 31, 1997 | 11,000 | 1,420 | 14.82% |
Dec 31, 1996 | 9,580 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
Company Name | Employees |
---|---|
Medtronic | 95,000 |
Pfizer | 88,000 |
Sanofi | 86,088 |
Danaher | 63,000 |
Bristol-Myers Squibb Company | 34,100 |
Amgen | 26,700 |
Stryker | 26,700 |
Gilead Sciences | 18,000 |
BSX News
- 7 days ago - Kidney Stone Management Market Forecast Report, 2024-2032 - Cook Group, Richard Wolf, Boston Scientific, and Dornier MedTech Actively Engaged in M&As to Increase Share - GlobeNewsWire
- 10 days ago - Boston Scientific to Participate in the 2024 UBS Global Healthcare Conference - PRNewsWire
- 11 days ago - Boston Scientific Announces Agreement to Acquire Cortex, Inc. - PRNewsWire
- 12 days ago - Boston Scientific Corporation (BSX) Business Update Earnings Call Transcript - Seeking Alpha
- 14 days ago - Why The Fundamentals Make Me Bullish On Boston Scientific - Seeking Alpha
- 15 days ago - Why is Boston Scientific Stock Trading Lower On Wednesday? - Benzinga
- 15 days ago - ACURATE neo2™ Aortic Valve System Data Presented at Late-Breaking Clinical Trial Session at TCT 2024 - PRNewsWire
- 22 days ago - Boston Scientific Profit Falls Even as Demand for Its Heart Products Surges - Investopedia